Related Experiment Video
Updated: Mar 25, 2026

Opsonophagocytic Killing Assay to Assess Immunological Responses Against Bacterial Pathogens
Published on: April 5, 2019
Optimization of Fermentation Conditions Using Design of Experiment (DoE) to Enhance the Production of Antigenic
Amol Dattatraya Mahajan1,2, Pramod Maruti Jadhav2, Avinash Rohidas Memane2
1MIT School of Bioengineering Sciences & Research, MIT Art Design and Technology University, Pune, India.
Insights
Optimizing Streptococcus pneumoniae fermentation using Design of Experiments (DoE) significantly boosted vaccine antigen yield. This data-driven approach enhances scalability for pneumococcal vaccines, addressing global health needs.
Area of Science:
- Biotechnology
- Microbiology
- Vaccine Development
Background:
- Pneumococcal pneumonia, caused by Streptococcus pneumoniae, is a significant global health concern, particularly for young children and the elderly.
- There is a critical need for scalable and high-yield production methods for Streptococcus pneumoniae vaccines.
Purpose of the Study:
- To develop an innovative and optimized fermentation platform for Streptococcus pneumoniae (serotype 18C) production.
- To enhance the yield of antigenic capsular polysaccharide through a data-driven approach.
Main Methods:
- Utilized a data-driven Design of Experiment (DoE) approach, specifically Plackett-Burman design (PBD), to optimize media composition and fermentation parameters.
- Investigated the effects of dextrose, MgSO4, pH, and aeration on bacterial growth and polysaccharide yield.
- Employed downstream processing including centrifugation and diafiltration (100 kDa) for product recovery and purification.
Main Results:
- Identified pH 7.1 as optimal for significantly enhancing antigenic capsular polysaccharide yield.
- ANOVA analysis revealed a synergistic effect between dextrose and MgSO4 concentrations.
- Lower aeration levels (0.2 vvm) were found to favor bacterial growth, consistent with the microaerophilic nature of S. pneumoniae.
Conclusions:
- The optimized fermentation platform using PBD sets a new benchmark for pneumococcal fermentation, improving vaccine antigen yield and addressing scalability challenges.
- Precise modulation of fermentation conditions is key to enhancing vaccine antigen production for industrial manufacturing.
- This adaptive, data-driven bioprocess innovation paves the way for next-generation pneumococcal vaccine development.
Abstract:
Pneumococcal pneumonia, caused by Streptococcus pneumoniae, has emerged as a global health threat, especially in children below 5 years of age and elderly population. S. pneumoniae remains a major global health threat which necessitates scalable and high-yield vaccine production. This study presents an innovative fermentation platform for S. pneumoniae (serotype 18C) by optimizing an already refined media composition using data-driven Design of Experiment (DoE) approach. Unlike conventional applications, Plackett-Burman design (PBD) was strategically employed beyond screening, identifying statistically significant parameters and the interaction between key factors of dextrose, MgSO4, pH, and aeration. Results reveal that pH level of 7.1 significantly enhances the antigenic capsular polysaccharide yield. Further, ANOVA analysis confirmed a strong synergistic effect between dextrose and MgSO4. In addition, the present study also finds that fermentation at lower level of aeration (0.2 vvm) favors the bacterial growth aligning with S. pneumoniae's facultative anaerobic or microaerophilic nature. The downstream processing integrating centrifugation and diafiltration (100 kDa) improves the product recovery and purity reinforcing the process efficiency. The unconventional application of PBD combined with systematic optimization of refined process sets a new benchmark for pneumococcal fermentation strategies. The findings demonstrate that precise modulation of fermentation conditions can enhance the vaccine antigen yield addressing the scalability challenges in industrial production. Future work may focus on extending this DoE-based platform to other serotypes of S. pneumoniae and refining fermentation kinetics for next generation pneumococcal vaccine. This study not only challenges the traditional experimental set up, but paves the way for adaptive, data-driven bioprocess innovations in vaccine manufacturing.
Related Concept Videos
Bioreactor Controls-III
Production of Antibiotics
Methods of Medium Optimization
Scale-Up Processes

